Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute montelukast response as a predictor of long-term response in exercise-induced bronchoconstriction
NL-OMON34924Phase 4Active, not recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of montelukast in asthma and exercise-induced bronchospasm (EIB), sponsored by Medisch Spectrum Twente. Started May 2010; status: active, not recruiting.
02
Drugs
montelukast
03
Conditions
asthmaexercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NL-OMON34924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34924.